Animated Video Explains Cyber-Security

October 26, 2016

By Mollie Shields-Uehling, President & CEO,
SAFE-BioPharma Association


Mollie Shields-Uehling

Mollie Shields-Uehling, President & CEO, SAFE-BioPharma Association

How do you explain complicated cyber-security issues in a way that is quick and not confusing?

That was our mission in creating a brief animated video about authentication and digital signatures. Even though it’s specifically about cyber-security in the life sciences, this little gem will be useful explaining issues and solutions to people in any sector.

Click on the image below to view. And, if you agree with my assessment, click “Like” and share with others.

 

 

 

 


Fuel the Digital Revolution in Life Sciences with SAFE-BioPharma

August 12, 2014

healthcare_pw_blog

by Patric Wiesmann August 11, 2014 As posted on www.docusign.com/blog-category/industry-news

by Patric Wiesmann
August 11, 2014

When we as consumers think about the critical medicines and treatments developed by life sciences organizations, we often don’t consider the many data and approval processes inherent in the research and commercialization process. The harsh reality is that despite global investment in breakthrough drugs and devices, the recent slowdown in the clinical and economic efficiency of the development lifecycle imperils the industry. Pricewaterhouse Coopers substantiates this threat of declining scientific productivity, reporting that companies face more stringent regulatory hurdles from the FDA and European Medicines Agency (EMA). Between 2012 and 2018, nearly $150 Billion of revenues will meet death by “patent cliff.”

Compliance and risk management are always top of mind in the shifting landscape of life sciences. And as multinationals continue to expand across borders, reaching global patient populations in BRIC and beyond, they need to meet new and different standards to effectively bring life-sustaining treatments to market.

DocuSign is delighted to have a longstanding partnership with SAFE-BioPharma, a leading life sciences industry association that works to enable pharmaceutical companies to adopt and implement fully digital workflows. Leveraging the SAFE-BioPharma digital identity credential to apply digital signatures and to authenticate a user’s identity, companies are able to comply with digital authentication standards in different regions around the world.

I am honored to have recently attended a SAFE-BioPharma board meeting where I had the distinct privilege of accepting the SAFE-BioPharma DIGI Award for Innovative Product Compliance. The timing was ripe, as the dialogue among SAFE-BioPharma board members addressed the pressing need for life sciences companies to fully embrace digital adoption. I couldn’t agree more; it is high time that we champion efficiency and eradicate our product development cycle’s chief malady: Paper.

DocusignBlogPhoto

“DocuSign is a leader in delivering a secure and compliant platform that enables life sciences organizations to adopt a 100% digital solution,” said Mollie Shields-Uehling, President & CEO of SAFE-BioPharma. “Our member organizations, comprising most of the top 10 global BioPharma companies, realize that moving to secure, compliant end-to-end digital processes is required to modernize business, clinical and regulatory processes and bring medicines to patients faster and at lower cost.”

DocuSign has integrated with the global SAFE-BioPharma digital signature standard to provide fully digital workflows that facilitate compliance with 21 CFR Part 11.  We look forward to our dynamic partnership with SAFE-BioPharma and the opportunity to meaningfully help global life sciences organizations develop and commercialize treatments with greater clinical and economic efficiency.

About the Author

Patric Wiesmann joined DocuSign in 2011 and serves as Managing Director for Healthcare and Life Sciences. Patric brings over 20 years of experience in executive leadership, managing global sales and marketing organizations and serving both public and private industries including healthcare, software/technology and consumer products.  He previously held Corporate Sales and Sales leadership positions at American Hospital Supply and Baxter International. At DocuSign, he works with senior executives in customer and partner organizations to identify solutions that improve their ability to serve patients and improve compliance across their enterprises and around the world.


The New Credential Order Emerges

January 11, 2013
Peter Alterman

Peter Alterman, PhD., Chief Operating Officer, SAFE Bio-Pharma Association

We’ll soon look back on 2012 as the year the future of electronic identity credentialing began to appear out of the cloud (pun intended).For years, the electronic identity credentialing space has been trying to climb out of the siloed userID/password hole. Many initiatives and technologies have been thrown at the problem, with notable successes such as the academic InCommon and related academic federations based on the Shibboleth/SAML technology sponsored by OASIS and Internet2.

These local successes – many with millions of users, so I mean no slight when I call them local – led to the federated identity management initiatives. The US government has a lot to be proud of in this space, having initiated and then led a number of the technical, policy and practice efforts to enable federated identity management globally.

Alas, the

world of federated identity will soon be lost to the archives.

Three converging currents predict what is about to happen:

  1. For years, , common credit cards in Europe have carried a digital certificate chip. In 2012, the US credit industry committed to converting from the ubiquitous mag stripe format to a smartcard compatible with the European credit card by 2015.
  2. A bill has been introduced in Congress to direct the Centers for Medicare and Medicaid Services (CMS) to issue high assurance digital credentials to all citizens receiving CMS benefits; this encompasses every citizen over the age of 65 and many millions of others receiving Medicare and/or Medicaid services. Whether it passes or not, it points to the trend of governments credentialing their citizens. Many European and Pacific Rim nations already issue and manage high assurance digital credentials to their citizens.
  3. Verizon has announced that it is moving from being a telecom company to an e-services company. The first step in this evolution is Verizon’s fourth quarter issuance of its Universal Identity Solution, zero-footprint credential. It links to all of the subscriber’s mobile and digital devices and is both user-friendly and high assurance.

These three sources: credit industry, governments and telcos, will credential every one of us, ending the current situation in which companies, websites, identity federations and communities of interest issue many kinds of credentials. This will be accompanied by the end of debates over technology interchange protocols, trust levels, policies, goals and standards.

The new challenge will be getting the Big Dogs to adopt three of the four goals of NSTIC: interoperability, user-friendliness and privacy enhancing. (In all likelihood the fourth, voluntary opt-in, a relic of the birth of the goals in a US government office, is likely to be deemed unnecessary and irrelevant by the telcos and the credit card consortium.)

There will be clear winners in this Brave New World. US businesses would do well to align with Federal PKI Architecture and/or FICAM-approved credential issuers. SAFE-BioPharma credentials fall into this category, and are likely to be among the long-term smart options. Relying on bank-issued ATM cards, next-generation smartcard-based credit cards, and mobile-device-based credentials issued by the major telcos will also be good bets.


%d bloggers like this: